.. in simple terms , Cyp's technology , if proven fully , can produce unlimited numbers of stem cells for medical applications ... and do so very quickly .. and without genetic reversion ....
As Mr Benelong points out , whilst MSB's technology isn't quite so " pie in the sky " , they are much further down the commercialisation process than CYP is ...
... both companies offer high reward , high risk ... CYP being higher risk at this juncture , than MSB ..
.. in simple terms , Cyp's technology , if proven fully , can...
-
- There are more pages in this discussion • 294 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $44.01M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $9.344K | 37.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22597 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9523 | 1 |
View Market Depth
| Last trade - 15.55pm 23/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |